GVALX Mutual Fund

NAV$16.26

Fund Essentials - as of Mar 31, 2026

Net Assets
$32M
Expense Ratio
0.75%
Dividend Yield (Current)
10.65%
Holdings
247
Inception Date
Dec 31, 2015
Fund Family
Gotham Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+10.17%
1 Year+18.85%
3 Year+15.11%
5 Year+9.97%
10 Year+12.39%

Asset Allocation

Stocks: 99.54%
Cash: 0.46%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
CATCaterpillar, Inc.2.27%
NUVLNuvalent Inc-A2.25%
VZVerizon Communications, Inc.1.72%
PFEPfizer Inc USD 0.051.53%
AMATApplied Materials, Inc.1.48%
Top 10 Concentration: 15.99%Report Date: Mar 31, 2026
Download all 247 holdings for GVALX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
10.65%
Frequency
Annually
Latest Distribution
$2.87
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how GVALX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

GVALX Mutual Fund Overview

GVALX Mutual Fund (Gotham Large Value Fund Institutional Class) is managed by Gotham Funds with $32.1M in net assets. GVALX expense ratio is 0.75%, holding 247 positions across sectors including Industrials, Health Care, Consumer Staples. Inception date: 2015-12-31.

GVALX performance shows a YTD return of 10.17%. The 1-year return is 18.85% and the 5-year return is 9.97%. GVALX dividend yield stands at 10.65%, paid annually.

GVALX top holdings include Caterpillar, Inc. (2.3%), Nuvalent Inc-A (2.3%), Verizon Communications, Inc. (1.7%), Pfizer Inc USD 0.05 (1.5%), Applied Materials, Inc. (1.5%). View all GVALX holdings, sector breakdown, or dividend history.

GVALX can be compared against other funds using the overlap calculator or side-by-side comparison tool. GVALX alternatives are available via the screener, along with tax-loss harvesting opportunities.